South African vaccine manufacture, Biovac , is set to employ over 700 high-end skilled individuals.
It has secured a financing package of one-eight-billion rand from the International Finance Corporation, the European Commission, and European Investment Bank.
It will build Africas first end-to-end multi-vaccine manufacturing site in Cape Town.
